Impact of fixed-dose combination versus single-component therapy for benign prostatic hyperplasia-related urinary symptoms on persistence, adherence, and satisfaction in a real-life setting

2025
journal article
article
dc.affiliationWydział Lekarski : Katedra Urologiipl
dc.cm.idOmegaUJCM612eced38e9e40d6b07b2ba2dacca467pl
dc.contributor.authorMałkowski, Mateuszpl
dc.contributor.authorChudek, Annapl
dc.contributor.authorAlmgren-Rachtan, Agnieszkapl
dc.contributor.authorChudek, Jerzy Tadeuszpl
dc.contributor.authorChłosta, Piotr - 228386 pl
dc.date.accession2025-09-24pl
dc.date.accessioned2025-11-23T23:32:22Z
dc.date.available2025-11-23T23:32:22Z
dc.date.createdat2025-11-23T23:32:22Zen
dc.date.issued2025pl
dc.date.openaccess0pl
dc.description.accesstimew momencie opublikowaniapl
dc.description.number10pl
dc.description.versionostateczna wersja wydawcypl
dc.description.volume18pl
dc.identifier.articleid1439pl
dc.identifier.doi10.3390/ph18101439pl
dc.identifier.eissn1424-8247pl
dc.identifier.issn1424-8247pl
dc.identifier.urihttps://ruj.uj.edu.pl/handle/item/565937
dc.identifier.weblinkhttps://www.mdpi.com/1424-8247/18/10/1439pl
dc.languageengpl
dc.language.containerengpl
dc.pbn.affiliationDziedzina nauk medycznych i nauk o zdrowiu : nauki medyczne
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceCC-BYpl
dc.share.typeOtwarte czasopismopl
dc.subtypeArticlepl
dc.titleImpact of fixed-dose combination versus single-component therapy for benign prostatic hyperplasia-related urinary symptoms on persistence, adherence, and satisfaction in a real-life settingpl
dc.title.journalPharmaceuticalspl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Katedra Urologii
dc.cm.idOmegapl
UJCM612eced38e9e40d6b07b2ba2dacca467
dc.contributor.authorpl
Małkowski, Mateusz
dc.contributor.authorpl
Chudek, Anna
dc.contributor.authorpl
Almgren-Rachtan, Agnieszka
dc.contributor.authorpl
Chudek, Jerzy Tadeusz
dc.contributor.authorpl
Chłosta, Piotr - 228386
dc.date.accessionpl
2025-09-24
dc.date.accessioned
2025-11-23T23:32:22Z
dc.date.available
2025-11-23T23:32:22Z
dc.date.createdaten
2025-11-23T23:32:22Z
dc.date.issuedpl
2025
dc.date.openaccesspl
0
dc.description.accesstimepl
w momencie opublikowania
dc.description.numberpl
10
dc.description.versionpl
ostateczna wersja wydawcy
dc.description.volumepl
18
dc.identifier.articleidpl
1439
dc.identifier.doipl
10.3390/ph18101439
dc.identifier.eissnpl
1424-8247
dc.identifier.issnpl
1424-8247
dc.identifier.uri
https://ruj.uj.edu.pl/handle/item/565937
dc.identifier.weblinkpl
https://www.mdpi.com/1424-8247/18/10/1439
dc.languagepl
eng
dc.language.containerpl
eng
dc.pbn.affiliation
Dziedzina nauk medycznych i nauk o zdrowiu : nauki medyczne
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licencepl
CC-BY
dc.share.typepl
Otwarte czasopismo
dc.subtypepl
Article
dc.titlepl
Impact of fixed-dose combination versus single-component therapy for benign prostatic hyperplasia-related urinary symptoms on persistence, adherence, and satisfaction in a real-life setting
dc.title.journalpl
Pharmaceuticals
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month

No access

No Thumbnail Available